US Patent 9687448 Nucleic acid lipid particle formulations
Patent 9687448 was granted and assigned to Alnylam Pharmaceuticals on June, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9687448 Nucleic acid lipid particle formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.